Legal Representation
Attorney
Monte L. Falcoff
USPTO Deadlines
Application History
29 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 7, 2014 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 7, 2014 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Aug 28, 2013 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 26, 2013 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 26, 2013 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 26, 2013 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 5, 2013 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 8, 2013 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 8, 2013 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 19, 2012 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 4, 2012 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Dec 3, 2012 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 19, 2012 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 9, 2012 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Nov 9, 2012 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 9, 2012 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 19, 2012 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Oct 19, 2012 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Oct 19, 2012 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Sep 25, 2012 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 25, 2012 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 25, 2012 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 20, 2012 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 20, 2012 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 20, 2012 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 20, 2012 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 17, 2012 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
| May 16, 2012 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 14, 2012 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, biosimilars, biopharmaceutical and veterinary preparations for the treatment of cancer, blood diseases, auto-immune diseases, infectious diseases and hereditary diseases
First Use Anywhere:
0
First Use in Commerce:
0
Class 040
Custom manufacture of pharmaceuticals, biosimilars, biopharmaceutical and veterinary preparations and proteins for the treatment of cancer, blood diseases, auto-immune diseases, infectious diseases and hereditary diseases
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research and development of pharmaceuticals, biosimilars, biopharmaceutical and veterinary preparations and medicines
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of an orange folded wave to the left of the wording "REVO HEMATOLOGY" in gray stylized font where the word "HEMATOLOGY" appears centered below the word "REVO".
Color Claim
The color(s) orange and grey is/are claimed as a feature of the mark.
Classification
International Classes
005
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"HEMATOLOGY"